Tune Therapeutics, Washington, United States
Dan is a seasoned industry analytical professional with a wealth of expertise in the field of flow cytometry method development, garnered through his tenure at the Fred Hutch Cancer Center, Juno Therapeutics, and Bristol Myers Squibb. Currently serving as a Product Development Scientist at Tune Therapeutics, Dan actively collaborates with multiple teams and diverse workflows. His focus is on crafting modular automation solutions that not only streamline processes but also exhibit remarkable ease of implementation. Dan's innovative approach ensures flexibility, allowing seamless adaptation to new platforms within the dynamic landscape of analytical sciences.
Disclosure information not submitted.
Automated Characterization Method for Validation of Epigenomic Editors in T Cells
Monday, February 5, 2024
11:00 AM – 11:20 AM EST